CSPC Pharmaceutical Group Limited (FRA:CVG)

Germany flag Germany · Delayed Price · Currency is EUR
1.002
+0.011 (1.16%)
Last updated: Jun 10, 2025
Market Cap 11.12B
Revenue (ttm) 3.45B
Net Income (ttm) 534.62M
Shares Out n/a
EPS (ttm) 0.05
PE Ratio 20.80
Forward PE 17.83
Dividend 0.03 (3.01%)
Ex-Dividend Date Jun 4, 2025
Volume n/a
Average Volume 3,849
Open 1.002
Previous Close 0.990
Day's Range 1.002 - 1.002
52-Week Range 0.511 - 1.002
Beta n/a
RSI 71.86
Earnings Date May 23, 2025

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 21,400
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol CVG
Full Company Profile

Financial Performance

In 2024, CSPC Pharmaceutical Group's revenue was 29.01 billion, a decrease of -7.76% compared to the previous year's 31.45 billion. Earnings were 4.33 billion, a decrease of -26.31%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.